华仁药业
(300110)
| 流通市值：46.42亿 | | | 总市值：46.46亿 |
| 流通股本：11.81亿 | | | 总股本：11.82亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 120,100,595.17 | 114,513,328.29 | 112,162,748.61 | 232,043,523.45 |
| 应收票据及应收账款 | 584,555,110.68 | 612,478,471.99 | 664,626,179.01 | 656,365,193.38 |
| 其中：应收票据 | 989,058.59 | 1,402,767.24 | 1,430,046.72 | 1,638,566.02 |
| 应收账款 | 583,566,052.09 | 611,075,704.75 | 663,196,132.29 | 654,726,627.36 |
| 应收款项融资 | 86,246,628.64 | 139,087,746.51 | 112,521,985.87 | 149,740,915.42 |
| 预付款项 | 47,526,886.2 | 59,829,301.28 | 40,284,829.11 | 38,521,219.95 |
| 其他应收款合计 | 1,369,964,879.32 | 1,369,643,512.53 | 1,371,029,375.15 | 1,364,138,561.77 |
| 存货 | 310,685,070.75 | 319,066,378.12 | 319,194,970.4 | 334,628,729.51 |
| 其他流动资产 | 19,721,985.64 | 15,067,917.96 | 15,044,824.6 | 15,988,116.19 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,538,801,156.4 | 2,629,686,656.68 | 2,634,864,912.75 | 2,791,426,259.67 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 15,984,624 | 15,984,624 | 15,984,624 | 15,984,624 |
| 投资性房地产 | 9,172,012.56 | 9,244,073.1 | 9,316,133.64 | 9,388,194.18 |
| 固定资产 | 1,020,323,150.12 | 1,038,968,307.38 | 1,053,523,312.03 | 1,072,846,506.92 |
| 在建工程 | 58,092,354.39 | 49,534,828.6 | 42,407,995.94 | 41,947,342.85 |
| 使用权资产 | 383,264.91 | 487,791.71 | 910,834.09 | 1,055,175.33 |
| 无形资产 | 307,728,313.87 | 310,503,473.11 | 313,809,564.29 | 318,531,668.97 |
| 开发支出 | 8,729,000.53 | 11,646,892.13 | 13,462,643.06 | 13,042,521.77 |
| 商誉 | 820,041,620.38 | 820,041,620.38 | 820,041,620.38 | 820,041,620.38 |
| 长期待摊费用 | 12,866,424.14 | 11,428,831.78 | 13,519,607 | 16,054,890.83 |
| 递延所得税资产 | 42,479,742.8 | 43,178,293 | 42,982,176.41 | 42,033,994.12 |
| 其他非流动资产 | 38,059,791.14 | 38,197,225.14 | 40,561,701.67 | 23,344,258.89 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,333,860,298.84 | 2,349,215,960.33 | 2,366,520,212.51 | 2,374,270,798.24 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,872,661,455.24 | 4,978,902,617.01 | 5,001,385,125.26 | 5,165,697,057.91 |
| 流动负债: | | | | |
| 短期借款 | 420,057,165.11 | 415,994,244.6 | 453,339,869.77 | 624,828,010.88 |
| 应付票据及应付账款 | 114,143,912.22 | 154,051,749.14 | 132,171,493.16 | 142,322,851.18 |
| 应付账款 | 114,143,912.22 | 154,051,749.14 | 132,171,493.16 | 142,322,851.18 |
| 合同负债 | 36,759,421.8 | 35,363,498.63 | 40,156,392.86 | 55,547,782.11 |
| 应付职工薪酬 | 15,674,346.65 | 14,971,379.27 | 16,935,053.48 | 22,985,569.55 |
| 应交税费 | 18,156,091.71 | 21,137,684.17 | 22,024,043.88 | 32,387,284.02 |
| 其他应付款合计 | 209,840,315.5 | 234,826,258.67 | 234,370,358.88 | 212,535,760.14 |
| 一年内到期的非流动负债 | 604,726,128 | 633,770,064.7 | 626,693,317.9 | 419,998,315.8 |
| 其他流动负债 | 4,778,724.83 | 4,597,254.82 | 5,220,331.07 | 5,654,444.36 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,424,136,105.82 | 1,514,712,134 | 1,530,910,861 | 1,516,260,018.04 |
| 非流动负债: | | | | |
| 长期借款 | 566,680,000 | 605,340,000 | 605,857,796.33 | 836,420,000 |
| 租赁负债 | 0 | 0 | 145,934.25 | 163,080.2 |
| 长期应付职工薪酬 | - | - | 0 | - |
| 递延收益 | 175,412.49 | 175,412.49 | 175,412.49 | 175,412.49 |
| 递延所得税负债 | 44,438,299.55 | 45,199,909.88 | 45,961,520.19 | 46,723,130.52 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 611,293,712.04 | 650,715,322.37 | 652,140,663.26 | 883,481,623.21 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,035,429,817.86 | 2,165,427,456.37 | 2,183,051,524.26 | 2,399,741,641.25 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,182,212,982 | 1,182,212,982 | 1,182,212,982 | 1,182,212,982 |
| 资本公积 | 528,044,115.47 | 528,044,115.47 | 528,044,115.47 | 528,044,115.47 |
| 盈余公积 | 84,617,614.5 | 84,617,614.5 | 84,617,614.5 | 84,617,614.5 |
| 未分配利润 | 969,921,499.96 | 947,603,591.33 | 950,039,935.03 | 899,217,018.15 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,764,796,211.93 | 2,742,478,303.3 | 2,744,914,647 | 2,694,091,730.12 |
| 少数股东权益 | 72,435,425.45 | 70,996,857.34 | 73,418,954 | 71,863,686.54 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,837,231,637.38 | 2,813,475,160.64 | 2,818,333,601 | 2,765,955,416.66 |
| 负债和股东权益合计 | 4,872,661,455.24 | 4,978,902,617.01 | 5,001,385,125.26 | 5,165,697,057.91 |
| 公告日期 | 2024-10-29 | 2024-08-30 | 2024-04-25 | 2024-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |